Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,33035542,clearance,"After intracameral administration (4.5 μg) of solubilized brinzolamide, aqueous humor concentrations were described with a two-compartment model, the estimated clearance was 4.12 μL/min, apparent volume of distribution at steady-state 673 μL, and terminal half-life 3.4 h.","Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration. ",CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33035542/),[μl] / [min],4.12,161404,DB01194,Brinzolamide
,33035542,apparent volume of distribution at steady-state,"After intracameral administration (4.5 μg) of solubilized brinzolamide, aqueous humor concentrations were described with a two-compartment model, the estimated clearance was 4.12 μL/min, apparent volume of distribution at steady-state 673 μL, and terminal half-life 3.4 h.","Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration. ",Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33035542/),μl,673,161405,DB01194,Brinzolamide
,33035542,terminal half-life,"After intracameral administration (4.5 μg) of solubilized brinzolamide, aqueous humor concentrations were described with a two-compartment model, the estimated clearance was 4.12 μL/min, apparent volume of distribution at steady-state 673 μL, and terminal half-life 3.4 h.","Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/33035542/),h,3.4,161406,DB01194,Brinzolamide
,33035542,absolute bioavailability,"After topical administration of 1% brinzolamide suspension (500 μg), absolute bioavailability based on aqueous humor AUC0-∞ was 0.10%.","Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration. ",F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33035542/),%,0.10,161407,DB01194,Brinzolamide
over,33035542,elimination half-life,After intravenous administration of brinzolamide solution (0.75 mg/kg) elimination half-life in plasma and whole blood appeared to be over two weeks.,"Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/33035542/),weeks,two,161408,DB01194,Brinzolamide
